SCH-563705
CAS No. 473728-58-4
SCH-563705( SCH563705 )
Catalog No. M14573 CAS No. 473728-58-4
A potent, orally bioavailable dual CXCR2/CXCR1 receptor antagonist with IC50 of 1.3 nM and 7.3 nM, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 683 | In Stock |
|
| 5MG | 620 | In Stock |
|
| 10MG | 938 | In Stock |
|
| 25MG | 1644 | In Stock |
|
| 50MG | 2186 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSCH-563705
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, orally bioavailable dual CXCR2/CXCR1 receptor antagonist with IC50 of 1.3 nM and 7.3 nM, respectively.
-
DescriptionA potent, orally bioavailable dual CXCR2/CXCR1 receptor antagonist with IC50 of 1.3 nM and 7.3 nM, respectively; demonstrates potent inhibition against both Gro-alpha and IL-8 induced hPMN migration (Chemotaxis: CXCR2 IC50=0.5 nM, CXCR1 IC50=37 nM); dose-dependently decreases paw thickness and clearly reduces inflammation, and bone and cartilage degradation in a mouse model of arthritis.
-
In VitroSCH 563705 (Compound 16) is a potent and orally available CXCR2 and CXCR1 antagonist, with IC50s of 1.3 nM, 7.3 nM and Kis of 1 and 3 nM, respectively. SCH 563705 shows potent inhibition against both Gro-a and IL-8 induced human neutrophil migration (chemotaxis IC50 = 0.5 nM, against 30 nM of Gro-a; chemotaxis IC50 = 37 nM, against 3 nM of IL-8). SCH 563705 potently inhibits mouse CXCR2 (IC50 = 5.2 nM).
-
In VivoSCH 563705 has good oral pharmacokinetic profiles in rats, mice, monkeys and dogs. SCH 563705 (50 mg/kg p.o) reduces blood Ly6G+ Ly6C+ neutrophil frequency and unchanged levels of Ly6GLy6Chi monocytes. SCH563705 (3-30 mg/kg p.o) treatment causes a dosedependent elevation in plasma levels of CXCL1.
-
SynonymsSCH563705
-
PathwayGPCR/G Protein
-
TargetChemokine Receptor
-
RecptorChemokine Receptor
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number473728-58-4
-
Formula Weight425.4776
-
Molecular FormulaC23H27N3O5
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥30mg/mL
-
SMILESCC(C)C1C=C(OC=1)[C@@H](CC)NC2=C(NC3C(O)=C(C=CC=3)C(=O)N(C)C)C(=O)C2=O
-
Chemical NameBenzamide, 2-hydroxy-N,N-dimethyl-3-[[2-[[(1R)-1-[4-(1-methylethyl)-2-furanyl]propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chao J, et al. Bioorg Med Chem Lett. 2007 Jul 1;17(13):3778-83.
2. Min SH, et al. Biochem Biophys Res Commun. 2010 Jan 1;391(1):1080-6.
molnova catalog
related products
-
AZD 5069
AZD 5069 (AZD5069)?is a potent, selective, slowly reversible and orally bioavailable CXCR2 antagonist that inhibits CXCL8 binding to CXCR2 with pIC50 of 9.1.
-
IT1t
A highly potent, selective, orally bioavailable CXCR4 inhibitor with binding IC50 of 8 nM for hCXCR4, IC50 of 1.1 nM in Ca2+-mobilization assays.
-
SB 332235
A potent, selective and competitive CXCR2 inhibitor that selectively inhibits CXCR2-mediated recruitment of β-arrestin-2 with pKi of 8.92.
Cart
sales@molnova.com